251 related articles for article (PubMed ID: 31780277)
1. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
2. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
Luo H; Zhao L; Leung J; Zhang R; Liu Z; Wang X; Wang B; Nie Z; Lei T; Li X; Zhou W; Zhang L; Wang Q; Li M; Zhou Y; Liu Q; Sun H; Wang Z; Liang S; Guo X; Tao Q; Wu K; Pan Y; Guo X; Fan D
Lancet; 2016 Jun; 387(10035):2293-2301. PubMed ID: 27133971
[TBL] [Abstract][Full Text] [Related]
3. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
4. Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial.
Qian YY; Ru N; Chen H; Zou WB; Wu H; Pan J; Li B; Xin L; Guo JY; Tang XY; Hu LH; Jin ZD; Wang D; Du YQ; Wang LW; Li ZS; Liao Z
Lancet Gastroenterol Hepatol; 2022 Mar; 7(3):238-244. PubMed ID: 35085482
[TBL] [Abstract][Full Text] [Related]
5. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
6. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
7. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
Elmunzer BJ; Foster LD; Serrano J; Coté GA; Edmundowicz SA; Wani S; Shah R; Bang JY; Varadarajulu S; Singh VK; Khashab M; Kwon RS; Scheiman JM; Willingham FF; Keilin SA; Papachristou GI; Chak A; Slivka A; Mullady D; Kushnir V; Buxbaum J; Keswani R; Gardner TB; Forbes N; Rastogi A; Ross A; Law J; Yachimski P; Chen YI; Barkun A; Smith ZL; Petersen B; Wang AY; Saltzman JR; Spitzer RL; Ordiah C; Spino C; Durkalski-Mauldin V;
Lancet; 2024 Feb; 403(10425):450-458. PubMed ID: 38219767
[TBL] [Abstract][Full Text] [Related]
10. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?
Döbrönte Z; Szepes Z; Izbéki F; Gervain J; Lakatos L; Pécsi G; Ihász M; Lakner L; Toldy E; Czakó L
World J Gastroenterol; 2014 Aug; 20(29):10151-7. PubMed ID: 25110443
[TBL] [Abstract][Full Text] [Related]
11. [Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis].
Döbrönte Z; Toldy E; Márk L; Sarang K; Lakner L
Orv Hetil; 2012 Jun; 153(25):990-6. PubMed ID: 22714033
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
[No Abstract] [Full Text] [Related]
13. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
14. Optimal dilation time for combined small endoscopic sphincterotomy and balloon dilation for common bile duct stones: a multicentre, single-blinded, randomised controlled trial.
Meng W; Leung JW; Zhang K; Zhou W; Wang Z; Zhang L; Sun H; Xue P; Liu W; Wang Q; Zhang J; Wang X; Wang M; Shao Y; Cai K; Hou S; Li Q; Zhang L; Zhu K; Yue P; Wang H; Zhang M; Sun X; Yang Z; Tao J; Wen Z; Wang Q; Chen B; Shao Q; Zhao M; Zhang R; Jiang T; Liu K; Zhang L; Chen K; Zhu X; Zhang H; Miao L; Wang Z; Li J; Yan X; Wang F; Zhang L; Suzuki A; Tanaka K; Nur U; Weiderpass E; Li X
Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):425-434. PubMed ID: 31003961
[TBL] [Abstract][Full Text] [Related]
15. Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography.
Luo H; Wang X; Zhang R; Liang S; Kang X; Zhang X; Lou Q; Xiong K; Yang J; Si L; Liu W; Liu Y; Zhou Y; Wang S; Yang M; Chen W; Han Y; Shang G; Yang X; He Y; Zou Q; Guo W; Dai Y; Zeng W; Zhu X; Gong R; Li X; Nie Z; Wang Q; Wang L; Pan Y; Guo X; Fan D
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1597-1606.e5. PubMed ID: 30391434
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.
Elmunzer BJ; Scheiman JM; Lehman GA; Chak A; Mosler P; Higgins PD; Hayward RA; Romagnuolo J; Elta GH; Sherman S; Waljee AK; Repaka A; Atkinson MR; Cote GA; Kwon RS; McHenry L; Piraka CR; Wamsteker EJ; Watkins JL; Korsnes SJ; Schmidt SE; Turner SM; Nicholson S; Fogel EL;
N Engl J Med; 2012 Apr; 366(15):1414-22. PubMed ID: 22494121
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing the efficacy of single-dose and double-dose administration of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
Lai JH; Hung CY; Chu CH; Chen CJ; Lin HH; Lin HJ; Lin CC
Medicine (Baltimore); 2019 May; 98(20):e15742. PubMed ID: 31096538
[TBL] [Abstract][Full Text] [Related]
18. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.
Siddiqui AA; Patel D; Kaplan J; Zabolotsky AH; Loren D; Kowalski T; Ghumman SS; Adler DG; Munigal S; Hayat U; Eloubeidi MA
Dig Dis Sci; 2015 Aug; 60(8):2509-15. PubMed ID: 25868629
[TBL] [Abstract][Full Text] [Related]
19. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of high-dose rectal diclofenac suppository and epinephrine spray on duodenal papilla for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Dar HA; Shah A; Javid G; Khan MA; Singh B; Sheikh NA; Ashraf A; Mohammad S
Indian J Gastroenterol; 2021 Oct; 40(5):483-491. PubMed ID: 34767149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
